REFERENCES
- Ciccarelli, et al. The epidemiology of prolactinomas. Pituitary 2005; 8(1)3–6
- Heaney, et al. Functional role of estrogen in pituitary tumor pathogenesis. J. Clin Invest 2002; 109(2)277–283
- Gürlek A, Karavitaki N, Ansorge O, Wass J A. What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics. Eur J Endocrinol 2007; 156(2)143–153
- Kerbel R S. Tumor angiogenesis. N Engl J Med 2008; 358(19)2039–2049
- Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285(21)1182–1186
- Niveiro M, Aranda F I, Peiró G, Alenda C, Picó A. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol 2005; 36(10)1090–1095
- Turner H E, Nagy Z, Gatter K C, et al. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 2000; 85(3)1159–1162
- Turner H E, Nagy Z, Gatter K C, et al. Angiogenesis in pituitary adenomas – relationship to endocrine function, treatment and outcome. J Endocrinol 2000; 165(2)475–481
- Di Ieva A, Grizzi F, Ceva-Grimaldi G, et al. Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue. Journal of Anatomy 2007; 211(5)673–680
- Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer B W. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study. Endocr Pathol 1995; 6(2)115–124
- Schechter J. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 1972; 67(1)109–126
- Takada K, Yamada S, Teramoto A. Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas. Endocr Pathol 2004; 15(2)131–139
- Fukui S, Nawashiro H, Otani N, et al. Vascular endothelial growth factor expression in pituitary adenomas. Acta Neurochir Suppl 2003; 86: 519–521
- Fukui S, Otani N, Nawashiro H, et al. The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 2003; 10(3)320–324
- Lloyd R V, Scheithauer B W, Kuroki T, et al. Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 1999; 10(3)229–235
- McCabe C J, Boelaert K, Tannahill L A, et al. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 2002; 87(9)4238–4244
- Hunter J A, Skelly R H, Aylwin S J, et al. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur J Endocrinol 2003; 148(2)203–211
- Zhang X, Horwitz G A, Heaney A P, et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 1999; 84(2)761–767
- Gruszka A, Kunert-Radek J, Pawlikowski M, Stepien H. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas. Pituitary 2005; 8(2)163–168
- Iuchi T, Saeki N, Osato K, Yamaura A. Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas. Acta Neurochirurgica 2000; 142(12)1345–1351
- Stanfield J P. The blood supply of the human pituitary gland. J Anat 1960; 94: 257–273
- de l a, Torre N G, Wass J A, Turner H E. Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas. Frontiers of Hormone Research 2004; 32: 133–145